Search Within

Kevin Joseph Curran

  1. "Elsevier Inc."
Formats
  1. Meeting Abstract (12)
  2. Journal Article (5)
  3. Review (4)
Groups
  1. Pediatrics, Department of (21)
  2. Stem Cell Transplantation and Cellular Therapy Service (21)
  3. Department of Medicine (15)
  4. GSK Faculty (14)
  5. Tow Center for Developmental Oncology (TCDO) (14)
  6. Immunology Program Faculty (13)

More Groups

People
  1. Nancy Kernan (14)
  2. Susan Prockop (13)
  3. Andromachi Scaradavou (12)
  4. Richard O'Reilly (12)
  5. Farid Boulad (10)
  6. Jaap Jan Boelens (9)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (5)
  6. 2019 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (12)
  2. Transplantation and Cellular Therapy (6)
  3. Best Practice and Research: Clinical Haematology (1)
  4. Seminars in Oncology Nursing (1)
  5. eClinicalMedicine (1)
Publishers
  1. Elsevier Inc. (21)

Results (21)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rabbit anti-thymocyte globulin (ATG) exposure after ex vivo T-cell depleted hematopoietic cell transplantation is highly variable and impacts immune reconstitution in pediatric and young adult patients
    Meeting Abstract

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Spitzer, B.; Scaradavou, A.; Curran, K. J.; Cancio, M.; van Roessel, I.; Kernan, N. A.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Utilization of CAR T cell therapy in pediatric patients
    Review

    Szenes, V.; Curran, K. J.
    Seminars in Oncology Nursing (2019)

    Fulltext@MSK | Save
  • ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
    Review

    Lee, D. W.; Santomasso, B. D.; Locke, F. L.; Ghobadi, A.; Turtle, C. J.; Brudno, J. N.; Maus, M. V.; Park, J. H.; Mead, E.; Pavletic, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Building a CAR garage: Preparing for the delivery of commercial CAR T cell products at Memorial Sloan Kettering Cancer Center
    Journal Article

    Perica, K.; Curran, K. J.; Brentjens, R. J.; Giralt, S. A.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Busulfan, melphalan, and thiotepa conditioning for allogeneic hematopoietic stem cell transplantation (HSCT) of pediatric patients with acute leukemia and central nervous system (CNS) disease
    Meeting Abstract

    Forlenza, C. J.; Kobos, R.; Kernan, N. A.; Scaradavou, A.; Prockop, S. E.; Curran, K.; Shukla, N.; Steinherz, P. G.; O'reilly, R.; Boulad, F.
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save